ALPN - Alpine Immune gains on early clinical data for kidney disease therapy
2023-11-02 14:45:07 ET
More on Alpine Immune
- Alpine Immune Sciences: November 2023 Data Release Could Get Ball Rolling
- Alpine Immune Sciences: Going Strong But For How Long?
- Alpine Immune Sciences appoints Wolfgang Dummer as CMO
- Seeking Alpha’s Quant Rating on Alpine Immune Sciences
- Historical earnings data for Alpine Immune Sciences
For further details see:
Alpine Immune gains on early clinical data for kidney disease therapy